Johanna DiStefano, The Translational Genomics Research Institute (IMAGE)
Caption
'To our knowledge, this is the first study to apply a high-throughput sequencing approach to the investigation of liver miRNAs in NAFLD-related liver damage,' Dr. Johanna DiStefano, Professor and Director of TGen's Diabetes, Cardiovascular & Metabolic Diseases Division, and the study's senior author.
Credit
Photo courtesy of TGen
Usage Restrictions
None
License
Licensed content